Literature DB >> 3104290

Effects of bronchoconstriction on respiratory muscle activity during expiration.

A Oliven, E C Deal, S G Kelsen, N S Cherniack.   

Abstract

The effect of methacholine-induced bronchoconstriction on the electrical activity of respiratory muscles during expiration was studied in 12 anesthetized spontaneously breathing dogs. Before and after aerosols of methacholine, diaphragm, parasternal intercostal, internal intercostal, and external oblique electromyograms were recorded during 100% O2 breathing and CO2 rebreathing. While breathing 100% O2, five dogs showed prolonged electrical activity of the diaphragm and parasternal intercostals in early expiration, postinspiratory inspiratory activity (PIIA). Aerosols of methacholine increased pulmonary resistance, decreased tidal volume, and elevated arterial PCO2. During bronchoconstriction, when PCO2 was varied by CO2 rebreathing, PIIA was shorter at low levels of PCO2, and external oblique and internal intercostal were higher at all levels of PCO2. Vagotomy shortened PIIA in dogs with prolonged PIIA. After vagotomy, methacholine had no effects on PIIA but continued to increase external oblique and internal intercostal activity at all levels of PCO2. These findings indicate that bronchoconstriction influences PIIA through a vagal reflex but augments expiratory activity, at least in part, by extravagal mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104290     DOI: 10.1152/jappl.1987.62.1.308

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Abdominal muscle recruitment and PEEPi during bronchoconstriction in chronic obstructive pulmonary disease.

Authors:  M Gorini; G Misuri; R Duranti; I Iandelli; M Mancini; G Scano
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Elevation in lung volume and preventing catastrophic airway closure in asthmatics during bronchoconstriction.

Authors:  Juan S Osorio-Valencia; Chanikarn Wongviriyawong; Tilo Winkler; Vanessa J Kelly; Robert S Harris; Jose G Venegas
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.